On the possible increase in local tumour control probability for gliomas exhibiting low dose hyper-radiosensitivity using a pulsed schedule.

Using modelling, we have developed a treatment strategy for gliomas exhibiting low dose hyper-radiosensitivity (HRS) that employs both a reduced dose-rate and pulsed treatment dose delivery. The model exploits the low dose hypersensitivity observed in some glioma cell lines at low radiation doses. We show, based on in vitro data, that a pulsed delivery of external beam radiation therapy could yield significant increases in local control. We therefore propose a pulsed delivery scheme for the treatment of gliomas in which the daily treatment fraction is delivered using 0.20 Gy pulses, separated by three minutes for a time-averaged dose-rate of 0.0667 Gy/min. The dose per pulse of 0.2 Gy is near or below the transition dose observed in vitro for four of the five glioma cell lines we have studied. Using five established glioma cell lines our modelling demonstrates that our pulsed delivery scheme yields a substantial increase in tumour control probability (TCP).

[1]  E. Alexander,et al.  Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. , 1978, Journal of neurosurgery.

[2]  D P Byar,et al.  Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. , 1980, The New England journal of medicine.

[3]  J. Mazeron,et al.  A comparison between low dose rate radiotherapy and conventionally fractionated irradiation in moderately extensive cancers of the oropharynx. , 1985, International journal of radiation oncology, biology, physics.

[4]  R G Dale,et al.  The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. , 1985, The British journal of radiology.

[5]  C. Geard,et al.  Radioresponse of human astrocytic tumors across grade as a function of acute and chronic irradiation. , 1990, International journal of radiation oncology, biology, physics.

[6]  Low dose rate teletherapy using a telecaesium 137 unit radiobiological, physical and clinical considerations. , 1990, Australasian radiology.

[7]  G. Steel.  The ESTRO Breur lecture. Cellular sensitivity to low dose-rate irradiation focuses the problem of tumour radioresistance. , 1991, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  L. Dillehay,et al.  Response of glioblastoma cell lines to low dose rate irradiation. , 1991, International journal of radiation oncology, biology, physics.

[9]  P. Ostwald,et al.  Low dose rate teletherapy and tumour response. , 1993, Australasian radiology.

[10]  B. Marples,et al.  The effect of oxygen on low-dose hypersensitivity and increased radioresistance in Chinese hamster V79-379A cells. , 1994, Radiation research.

[11]  M. Salcman,et al.  Long-term survival in patients with malignant astrocytoma. , 1994, Neurosurgery.

[12]  Susan M. Chang,et al.  Reirradiation of primary CNS tumors. , 1996, International journal of radiation oncology, biology, physics.

[13]  M. Weller,et al.  Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53. , 1997, Neurological research.

[14]  M. McDermott,et al.  Interstitial brachytherapy for malignant brain tumors. , 1998, Seminars in surgical oncology.

[15]  Response and progression in recurrent malignant glioma. , 1999 .

[16]  S A Mitchell,et al.  The response of human glioma cell lines to low-dose radiation exposure. , 1999, International journal of radiation biology.

[17]  P Lambin,et al.  Low-dose hypersensitivity: current status and possible mechanisms. , 2001, International journal of radiation oncology, biology, physics.

[18]  S. Short,et al.  Low-dose hypersensitivity after fractionated low-dose irradiation in vitro. , 2001, International journal of radiation biology.

[19]  Wolfgang A Tomé,et al.  On the inclusion of proliferation in tumour control probability calculations for inhomogeneously irradiated tumours. , 2003, Physics in medicine and biology.

[20]  Mikael Karlsson,et al.  The effect of fraction time in intensity modulated radiotherapy: theoretical and experimental evaluation of an optimisation problem. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  B. Wouters,et al.  An Association between the Radiation-Induced Arrest of G2-Phase Cells and Low-Dose Hyper-Radiosensitivity: A Plausible Underlying Mechanism? , 2003, Radiation research.

[22]  J. Fowler,et al.  The effect of fraction time in intensity modulated radiotherapy: theoretical and experimental evaluation of an optimization problem (the real conclusions): in regard to Mu et al. Radiotherapy on Oncology 2003; 68: 181-87. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  B. Wouters,et al.  Low-Dose Hyper-radiosensitivity: A Consequence of Ineffective Cell Cycle Arrest of Radiation-Damaged G2-Phase Cells , 2004, Radiation research.

[24]  R. Mirimanoff,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[25]  D. Gridley,et al.  Low-dose/low-dose-rate radiation: a feasible strategy to improve cancer radiotherapy? , 2005 .

[26]  W. Tomé,et al.  Does a local bystander effect necessitate a revision of TCP models that are based on observed clinical data? , 2006, Acta oncologica.

[27]  D. Lea,et al.  The mechanism of the induction by radiation of chromosome aberrations inTradescantia , 1942, Journal of Genetics.